Skip to main content
Premium Trial:

Request an Annual Quote

The Next Big Thing (Maybe)

Premium

If you could poof into existence some far-out genomics technology, what would it be?

GT went from booth to booth at Boston’s DDT conference to find out.

“It’d be great if I could be the size of a molecule, and see everything going on around. Kind of like in Fantastic Voyage, but much smaller so I could see how it really works.”

Corey Jacklin, director of business development, Gene Logic

(shown with Athelney Woolnough, right, director of business development)

“A robot that could do entire sequencing instantaneously, instead of sequencing one base at a time.”

David Maas, engineer

CuraGen

 

“Something where you type in the sequence and drugs come out the other end.”

Mark Benedyk, senior director of business development

Aurora Biosciences

“That’s easy. I want a virtual guy to be here, or at least a virtual booth. I want a virtual clone of myself.” So where’s the prototype? “It’s in my basement.”

Venkatesh Gopal, applications scientist

Applied Biosystems

“It would be a magical incubator. I remember wanting one when I was at the bench. It could handle any temperature, any time, and a second later it’s all done.”

Scott O’Brien, technical services scientist

Stratagene

“An instrument that genotypes and brews cappuccino.” You mean it genotypes cappuccino? “No, it’s double function. It genotypes, and it also brews the cappuccino.”

John Boyce (right), East Coast sales manager

Sequenom

 

“So it’s called GenoDater, and it’s a genotype-based dating service. It’s Web-enabled and runs on a PDA, so you can exchange genotypes with other people who have PDAs. It’ll tell you all the important things about someone, like whether he leaves the seat up, cleanliness, what potential in-laws are like, cooking ability.”

Tanya Boyaniwsky, product specialist

Tristan Orpin (left), director of sales and marketing, Sequenom

 

“I can’t disclose that.”

David Chilvers, vice president of marketing

Lion Bioscience

compiled by Meredith Salisbury and Aaron J. Sender

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.